Remedent Inc (REMI) Gross Profit Margin starting from the third quarter 2020 to third quarter 2019, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Remedent Inc   (REMI)


Remedent Inc 's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

REMI Gross Profit Margin (Dec 31 2020)
Q3 		(Sep 30 2020)
Q2 		(Jun 30 2020)
Q1 		(Mar 31 2020)
Q4 		(Dec 31 2019)
Q3
Y / Y Revenue Change 28.77 %
Seq. Revenue Change 4.83 %
Revenue In Millions $0.34
Gross Profit Margin 61.94 %
Gross Profit Margin Total Ranking # 1191
Gross Profit In Millions $0.21
Y / Y Gross Profit Change 24.79 %
Seq. Gross Profit Change 0.09 %


Commenting Third Quarter 2020 Gross Profit Margin
Remedent Inc has managed to improve its Revenue sequentially to $0.34 millions by 4.83 % faster than Gross Profit increase of 0.09 % to $0.21 millions, this led to contraction in Gross Profit Margin to 61.94 %, below company average.


Observing third quarter 2020 results within Medical Equipment & Supplies industry 79 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin overall ranking has deteriorated relative to the three months before, from 1106 to 1191.
Learn about Gross Margin
REMI's Gross Profit Margin third quarter 2020 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 80
Healthcare Sector # 225
Overall # 1166

Gross Profit Margin Statistics
High Average Low
84.35 % 64.49 % 16.77 %
(Dec 31 2011)   (Mar 31 2014)


REMI Gross Income Trends • More of REMI's Profitabilty Ratios • REMI Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
REMI's Cumulative Gross Profit Margin
Medical Equipment & Supplies Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
REMI's Gross Profit Margin Profitability versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for REMI's Competitors
Gross Profit Margin Profit Margin for Remedent Inc 's Suppliers
Gross Profit Margin Profit Margin for REMI's Customers

You may also want to know
REMI's Annual Growth Rates REMI's Profitability Ratios REMI's Asset Turnover Ratio REMI's Dividend Growth
REMI's Roe REMI's Valuation Ratios REMI's Financial Strength Ratios REMI's Gross Profit Growth
REMI's Roa REMI's Inventory Turnover Ratio REMI's Growth Rates REMI's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Dec 31 2020, within Medical Equipment & Supplies Industry Gross Profit MarginDec 31 2020 MRQ Gross ProfitDec 31 2020 MRQ Revenue
Invo Fertility Inc   94.85 %$ 0.186  Millions$ 0.197  Millions
Bionik Laboratories Corp   94.69 %$ 0.171  Millions$ 0.180  Millions
Inari Medical Inc   92.42 %$ 44.925  Millions$ 48.611  Millions
Semler Scientific inc   91.83 %$ 11.087  Millions$ 12.073  Millions
Sanara Medtech Inc   89.77 %$ 4.299  Millions$ 4.789  Millions
Si bone inc   89.73 %$ 19.869  Millions$ 22.144  Millions
Vycor Medical Inc   87.99 %$ 0.238  Millions$ 0.271  Millions
Fonar Corporation  87.48 %$ 18.515  Millions$ 21.164  Millions
Inmode Ltd   85.03 %$ 175.258  Millions$ 206.107  Millions
Inspire Medical Systems inc   84.44 %$ 38.848  Millions$ 46.009  Millions
Mimedx Group Inc   84.22 %$ 57.730  Millions$ 68.548  Millions
Co diagnostics Inc   84.11 %$ 22.832  Millions$ 27.145  Millions
Avita Medical Inc   83.91 %$ 4.282  Millions$ 5.103  Millions
Surmodics Inc   83.21 %$ 18.554  Millions$ 22.297  Millions
Axogen inc   83.19 %$ 27.032  Millions$ 32.495  Millions
Abiomed Inc   82.25 %$ 190.553  Millions$ 231.663  Millions
Cerus Corporation  81.70 %$ 54.369  Millions$ 66.548  Millions
Vivos Therapeutics Inc   81.30 %$ 2.688  Millions$ 3.307  Millions
Novocure Limited  80.45 %$ 115.817  Millions$ 143.953  Millions
Orthopediatrics Corp  79.89 %$ 15.118  Millions$ 18.924  Millions
Electromed Inc   79.25 %$ 7.525  Millions$ 9.496  Millions
Cytosorbents Corporation  78.86 %$ 9.428  Millions$ 11.956  Millions
Advanced Biomedical Technologies Inc   78.52 %$ 0.037  Millions$ 0.047  Millions
Cardiovascular Systems Inc   78.31 %$ 50.249  Millions$ 64.169  Millions
Zynex inc   77.90 %$ 19.946  Millions$ 25.605  Millions
Antares Pharma Inc   77.52 %$ 34.214  Millions$ 44.133  Millions
Agape Atp Corporation  77.25 %$ 0.398  Millions$ 0.516  Millions
Therapeutic Solutions International Inc   76.88 %$ 0.014  Millions$ 0.018  Millions
Stereotaxis Inc   76.52 %$ 5.222  Millions$ 6.825  Millions
Neuronetics Inc   75.85 %$ 11.816  Millions$ 15.579  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.